Bal Pharma is considering raising funds through the issuance of preferential warrants to its promoters on May 27, 2026. This fundraising initiative supplements an existing plan previously announced on May 18, 2026.

Bal Pharma will convene a board meeting on May 27, 2026, to discuss their financial results, dividend distribution, and stock options. Due to insider trading regulations by SEBI, the trading window for this company is closed from April 1 until May 29, 2026.